GlobeNewswire 11-Aug-2017 10:00 AM
ADVISORY, Aug. 11, 2017 (GLOBE NEWSWIRE) --
What: PolarityTE, Inc. (Nasdaq:COOL), the owner of a novel regenerative medicine technology platform developed and patented by Denver Lough MD, PhD, will visit the Nasdaq MarketSite in Times Square.
In honor of the occasion, Dr. Denver Lough, Chairman of the Board, President, CEO, & Chief Scientific Officer, will ring the Closing Bell.
Where:Nasdaq MarketSite 4 Times Square 43rd & Broadway Broadcast Studio
When: Monday, August 14, 2017 3:45 p.m. to 4:00 p.m. ET
PolarityTE, Inc. Contact: John Stetson (385) 237-2365InvestorRelations@PolarityTE.com
Nasdaq MarketSite Media Contact: Emily Pan (646) email@example.com
Feed Information: Fiber Line (Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 VerticalFEC 3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media:For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit our Facebook page:http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit our Instagram page:http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our YouTube page:http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter page:http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our Tumblr page:http://nasdaq.tumblr.com/
Webcast: A live stream of the Nasdaq Closing Bell will be available at: https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution photograph of the Market Close, please go to http://business.nasdaq.com/discover/market-bell-ceremonies and click on the market close of your choice.
About PolarityTE, Inc.PolarityTE, Inc. is a regenerative medicine company positioned to be the first to successfully regenerate human skin. The Company's novel regenerative medicine platform was developed and patented by Chairman and Chief Executive Officer, Denver Lough M.D., Ph.D. This radical and proprietary technology is in development to employ a patient's own cells for the healing of full-thickness, functionally-polarized tissues. If clinically successful, the PolarityTE platform will provide medical professionals with a truly new paradigm in wound healing and reconstructive surgery by utilizing a patient's own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels, nerves, solid and hollow organs, and more. The PolarityTE platform leverages natural and biologically-sound principles which are readily adaptable to a wide spectrum of organ and tissue systems. This revolutionary technology, paired with the Company's world-renowned clinical advisory board, position PolarityTE to drastically change the field and future of translational regenerative medicine. More information can be found online at www.PolarityTE.com.
About Nasdaq:Nasdaq (Nasdaq:NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $12 trillion. To learn more, visit: http://business.nasdaq.com
Source: NASDAQ, Inc.